Consolidated Statements of Operations. 3 Consolidated Statements of Stockholders' Equity (Deficit).................. 4
Consolidated Statements of Operations. 50 Consolidated Statement of Stockholders' Equity......................................... 51 Consolidated Statements of Cash Flows.................................................. 52 Notes to Consolidated Financial Statements............................................. 53 The Board of Directors and Stockholders Gilead Sciences, Inc. We have audited the accompanying consolidated balance sheets of Gilead Sciences, Inc. as of December 31, 1998 and 1997 and the related consolidated statements of operations, stockholders' equity and cash flows for each of the three years in the period ended December 31, 1998. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Gilead Sciences, Inc. at December 31, 1998 and 1997, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 1998, in conformity with generally accepted accounting principles. Palo Alto, California January 21, 1999 GILEAD SCIENCES, INC. CONSOLIDATED BALANCE SHEETS DECEMBER 31, 1998 1997 ASSETS Current assets: Cash and cash equivalents........................................... $ 32,475 $ 31,990 Total current assets.................................................. 288,310 340,258 Property and equipment, net........................................... 10,182 10,313 Other assets.......................................................... 4,368 1,498 $ 302,860 $ 352,069 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable.................................................... $ 3,422 $ 3,303 Deferred revenue.....................................................
Consolidated Statements of Operations. Years Ended June 30, 1998, 1997 and 1996....................... 31 Consolidated Statements of Cash Flows -- Years Ended June 30, 1998, 1997 and 1996....................... 32
Consolidated Statements of Operations. (In thousands, except per share data) (In thousands)
Consolidated Statements of Operations. 24 Consolidated Statements of Comprehensive Income (Loss)..................................................... 25
Consolidated Statements of Operations. Consolidated Statements of Comprehensive Income....
Consolidated Statements of Operations. December 31 1999 1998 1997 ----------------------------------------- (In Thousands, except per share data) Revenue $ 22,138 $ 6,953 $ 43 Cost of revenue 22,006 8,765 83 ---------------------------------------- Gross margin (loss) 132 (1,812) (40) Expenses: Selling, general and administrative 53,667 27,873 12,788 Depreciation and amortization 3,060 1,455 235 ---------------------------------------- Loss from operations (56,595) (31,140) (13,063)
Consolidated Statements of Operations. (In millions, except per share data) Year Ended December 31, 2013 2012 2011 Revenues Expenses Earnings (loss) per share attributable to Realogy Holdings: Weighted average common and common equivalent shares of Realogy Holdings outstanding: Year Ended December 31, 2013 2012 2011 ASSETS LIABILITIES AND EQUITY (In millions) Year Ended December 31, Operating Activities Investing Activities Financing Activities
Consolidated Statements of Operations. (In thousands of U.S. dollars, except per share data) NINE MONTHS ENDED THREE MONTHS ENDED YEAR ENDED SEPTEMBER 30, SEPTEMBER 30, DECEMBER 31, 2003 2002 2003 2002 2002 ----------- ----------- ----------- ----------- ------------ (UNAUDITED) (UNAUDITED) (AUDITED) ------------------------- -------------------------- ------------ Revenues $ 635,223 $ 589,143 $ 214,275 $ 210,155 $ 827,456 Cost of revenues (464,882) (424,415) (158,078) (150,738) (595,512) Chief Scientist ("OCS") - (9,801) - - (9,801) ----------- ----------- ----------- ----------- ------------ Gross profit 170,341 154,927 56,197 59,417 222,143 ----------- ----------- ----------- ----------- ------------ Research and development costs, net 43,006 39,710 14,518 14,785 57,010 Marketing and selling expenses 50,696 47,289 15,573 17,346 65,691 General and administrative expenses 33,924 30,741 11,035 10,760 41,651 ----------- ----------- ----------- ----------- ------------ 127,626 117,740 41,126 42,891 164,352 ----------- ----------- ----------- ----------- ------------ Operating income 42,715 37,187 15,071 16,526 57,791 Financial expenses, net (3,467) (690) (161) (595) (3,035) Other income (expenses), net 332 (524) 241 (115) (462) ----------- ----------- ----------- ----------- ------------ Income before taxes on income 39,580 35,973 15,151 15,816 54,294 Taxes on income 10,502 6,810 3,900 1,565 9,348 ----------- ----------- ----------- ----------- ------------ 29,078 29,163 11,251 14,251 44,946 Equity in net earnings of affiliated companies and partnership 3,938 2,554 989 1,114 675 Minority interest 456 269 (234) 139 (508) ----------- ----------- ----------- ----------- ------------ Net income $ 33,472 $ 31,986 $ 12,006 $ 15,504 $ 45,113 =========== =========== =========== =========== ============ Earnings per share Basic earnings per share $ 0.86 $ 0.83 $ 0.31 $ 0.40 $ 1.17 =========== =========== =========== =========== ============ Weighted average number of shares used in computation (in thousands) 38,994 38,459 39,168 38,515 38,489 =========== =========== =========== =========== ============ Diluted earnings per share $ 0.83 $ 0.80 $ 0.30 $ 0.39 $ 1.13 =========== =========== =========== =========== ============ Weighted average number of shares used in computation (in thousands) 40,198 39,896 40,406 39,772 39,863 =========== =========== =========== =========== ============ THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THE CONSOLIDATED FINANCIAL STATEMENTS. ELBIT SYSTEMS LTD. AND ITS SUBSIDIAR...
Consolidated Statements of Operations for Years Ended June 30, 1996, 1995, and 1994.......................................................
